mRNA technologies paint an optimistic future in cancer treatment.
immuno-oncology
Posted inClinical Trials, Oncology
Autogene Cevumeran: Powerful mRNA Vaccine Against Pancreatic Cancer
Personalized immunotherapy prolonged life in one-third of patients with pancreatic ductal adenocarcinoma.
Posted inClinical Trials, Oncology
Liver Cancer: Personalized Vaccine for Complete Remission
Geneos Therapeutics has figured out how to cure unresectable hepatocellular carcinoma.
Posted inNew Drugs, Oncology, Regulatory
Tevimbra: Immuno-Oncologic Treatment for Esophageal Cancer
Tislelizumab for the treatment of unresectable or metastatic esophageal squamous cell carcinoma.
Posted inOncology, Research
Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma
Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
Posted inMergers & Acquisitions, Oncology
Takeda Bets on Promising Gamma Delta T-cell Immunotherapy
UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.